Loading...

FITC anti-mouse Ly-6C Antibody

Pricing & Availability
Clone
HK1.4 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus C
Isotype
Rat IgG2c, κ
Ave. Rating
Submit a Review
Product Citations
publications
HK1dot4_FITC_011409.jpg
C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
  • HK1dot4_FITC_011409.jpg
    C57BL/6 bone marrow cells stained with HK1.4 FITC (gated on myeloid cell population)
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
128005 50 µg £61
Check Availability


Need larger quantities of this item?
Request Bulk Quote
128006 500 µg £201
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Most hematopoietic cells express one or more members of Ly-6 family. The expression of Ly-6 varies with development stage and activation. Ly-6C is a 14-17 kD GPI-linked surface protein expressed on mouse monocyte/macrophage cells, endothelial cells, neutrophils, and some T cell subsets. Ly-6C is reported to be an indicator of memory CD8+ T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  2. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  3. Zaman R, et al. 2021. Immunity. :. PubMed
  4. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  5. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  6. Duan Y, et al. 2019. Circ Res. 125:969. PubMed
  7. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  8. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  9. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  10. Fang C, et al. 2022. J Pathol. 256:310. PubMed
  11. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  12. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  13. Helfen A, et al. 2022. Neoplasia. 28:100792. PubMed
  14. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  15. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  16. Campisi L, et al. 2022. Nature. 606:945. PubMed
  17. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  18. McAlpine CS, et al. 2022. J Exp Med. 219: . PubMed
  19. Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed
  20. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  21. Soni N, et al. 2022. FASEB Bioadv. 4:798. PubMed
  22. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  23. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  24. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  25. Hettwer J, et al. 2022. Cardiovasc Res. 118:2778. PubMed
  26. Fernández-García V, et al. 2022. Biomed Pharmacother. 148:112769. PubMed
  27. Chen K, et al. 2022. Adv Sci (Weinh). 9:e2104106. PubMed
  28. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  29. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  30. Sanmarco LM, et al. 2022. Nature. 611:801. PubMed
  31. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  32. Aso K, et al. 2023. Nat Commun. 14:984. PubMed
  33. Bautista CA, et al. 2023. Front Physiol. 14:1122348. PubMed
  34. He Y, et al. 2023. Biomolecules. 13:. PubMed
  35. Lin CH, et al. 2023. iScience. 26:106904. PubMed
  36. Rødahl I, et al. 2021. STAR Protoc. 2:100842. PubMed
  37. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  38. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  39. Keeter WC, et al. 2022. Eur Heart J Open. 2:oeac028. PubMed
  40. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  41. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  42. Jones NM, et al. 2019. BMC Cancer. 1.127777778. PubMed
  43. John S, et al. 2020. Sci Rep. 10:11377. PubMed
  44. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  45. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  46. Dong L, et al. 2021. Cancer Cell. . PubMed
  47. Zhang Z, et al. 2020. J Immunol. 204:3400. PubMed
  48. You Y, et al. 2016. Sci Rep. 6:20630. PubMed
  49. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  50. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  51. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  52. Shani O, et al. 2020. Cancer Res. 80:5317. PubMed
  53. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  54. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  55. Chen JS, et al. 2022. Sci Immunol. 7:eabl5652. PubMed
  56. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  57. Buzas K, et al. 2011. Cytokine. 55:429. PubMed
  58. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  59. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  60. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  61. McAlpine CS, et al. 2019. Nature. 566:383. PubMed
  62. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  63. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  64. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  65. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  66. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  67. Bhattacharya P, et al. 2022. PLoS Negl Trop Dis. 16:e0010224. PubMed
  68. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  69. Mirakaj V, et al. 2014. J Exp Med. 211:1037. PubMed
  70. Park Y, et al. 2013. Cancer Res . 73:5669. PubMed
  71. Schlegel M, et al. 2018. J Clin Invest. 128:4711. PubMed
  72. Al-Sharea A, et al. 2017. Cell Cycle. 10.1016/j.atherosclerosis.2017.08.010. PubMed
  73. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  74. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  75. Naler LB, et al. 2022. Commun Biol. 5:102. PubMed
  76. Eichin D, et al. 2015. PLoS One. 10: 0134721. PubMed
  77. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  78. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  79. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  80. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  81. Körner A, et al. 2019. Nat Commun. 10:633. PubMed
  82. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  83. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  84. Han D, et al. 2021. J Immunol Res. 6688053:2021. PubMed
  85. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  86. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  87. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  88. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  89. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  90. Cao Y, et al. 2015. J Biol Chem. 290: 23050-23063. PubMed
  91. Körner A, et al. 2019. Proc Natl Acad Sci U S A. 116:20623. PubMed
  92. Kulkarni U, et al. 2019. Mucosal Immunol. 12:545. PubMed
  93. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  94. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  95. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  96. Xu Y, et al. 2016. Arthritis Rheum. 67: 225-237. PubMed
  97. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  98. Li Y, et al. 2020. Cell Reports. 27(10):2809-2816.e3.. PubMed
  99. Körner A,et al. 2017. Cell Death Differ.. 10.1038/cdd.2017.177. PubMed
  100. He J, et al. 2019. J Clin Invest. 130. PubMed
  101. Monteran L, et al. 2022. Nat Commun. 13:5797. PubMed
  102. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  103. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  104. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  105. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  106. Poczobutt JM, et al. 2021. Am J Respir Cell Mol Biol. 64:629. PubMed
  107. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  108. Smith CA, et al. 2019. JCI Insight. 4. PubMed
  109. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  110. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  111. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  112. Lee S, et al. 2011. J Immunol. 186:6972. PubMed
  113. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  114. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  115. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  116. Derada Troletti C, et al. 2021. Cell Reports. 35(9):109201. PubMed
  117. Hou PP, et al. 2020. Molecular Cell. 78(6):1192-1206.e10. PubMed
  118. Xu G, et al. 2020. Cell Rep. 32:108170. PubMed
  119. Zhao T, et al. 2022. JCI Insight. 7:. PubMed
  120. Moore J, et al. 2015. Am J Physiol Heart Circ Physiol. 309: 906-917. PubMed
  121. León-Cabrera S, et al. 2014. Int J Biol Sci. 9 948 . PubMed
  122. Alvarez-Breckenridge C, et al. 2012. J Virol. 86:4566. PubMed
  123. Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed
  124. Kwak T, et al. 2020. Cell Reports. 33(13):108571. PubMed
  125. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  126. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  127. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  128. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  129. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  130. Hobbs BE, et al. 2021. Pathogens. 10:. PubMed
  131. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  132. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  133. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  134. Knuplez E, et al. 2021. British Journal of Pharmacology. 178(5):1234-1248. PubMed
  135. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  136. Tyagi A, et al. 2021. Nat Commun. 12:474. PubMed
  137. Tang S, et al. 2022. Virol J. 19:32. PubMed
  138. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  139. Roediger B et al. 2018. Cell. 175(2):530-543 . PubMed
  140. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  141. Caballero S, et al. 2017. Invest Ophthalmol Vis Sci. 58:5164. PubMed
  142. Chetty A, et al. 2021. Cell Host Microbe. 29:579. PubMed
  143. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
  144. Rahtes A, et al. 2020. Front Immunol. 1.484722222. PubMed
  145. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  146. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  147. Guan D, et al. 2021. Cell Death Dis. 12:431. PubMed
  148. Tummala G, et al. 2021. Invest Ophthalmol Vis Sci. 62:41. PubMed
  149. Aryal B, et al. 2016. Nat Commun. 7:12313. PubMed
  150. Ngkelo A, et al. 2016. J Exp Med. 213: 1353 - 1374. PubMed
  151. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  152. Ramanan D, et al. 2020. Cell. 181(6):1276-1290. PubMed
  153. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  154. Asahara M, et al. 2022. PLoS One. 17:e0276135. PubMed
  155. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  156. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  157. Jones GS, et al. 2020. mSphere. 5:. PubMed
  158. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  159. Aguado B, et al. 2015. Sci Rep. 5: 17566. PubMed
  160. Hilt ZT, et al. 2019. JCI Insight. 4:5. PubMed
  161. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  162. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  163. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  164. Reinke S, et al. 2020. Cell Reports. 30(8):2501-2511. PubMed
  165. Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
  166. Abe H, et al. 2019. Nat Commun. 10:2824. PubMed
RRID
AB_1186134 (BioLegend Cat. No. 128005)
AB_1186135 (BioLegend Cat. No. 128006)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All Ly-6C Reagents Request Custom Conjugation
Description Clone Applications
Pacific Blue™ anti-mouse Ly-6C HK1.4 FC
APC anti-mouse Ly-6C HK1.4 FC
Purified anti-mouse Ly-6C HK1.4 FC,IHC-F
Biotin anti-mouse Ly-6C HK1.4 FC
FITC anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 647 anti-mouse Ly-6C HK1.4 FC
PE anti-mouse Ly-6C HK1.4 FC
PerCP/Cyanine5.5 anti-mouse Ly-6C HK1.4 FC
PE/Cyanine7 anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 488 anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 700 anti-mouse Ly-6C HK1.4 FC
APC/Cyanine7 anti-mouse Ly-6C HK1.4 FC
PerCP anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 570™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 421™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 510™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 605™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 711™ anti-mouse Ly-6C HK1.4 FC
Purified anti-mouse Ly-6C (Maxpar® Ready) HK1.4 FC,CyTOF®
Brilliant Violet 785™ anti-mouse Ly-6C HK1.4 FC
PE/Dazzle™ 594 anti-mouse Ly-6C HK1.4 FC
APC/Fire™ 750 anti-mouse Ly-6C HK1.4 FC
TotalSeq™-A0013 anti-mouse Ly-6C HK1.4 PG
Brilliant Violet 650™ anti-mouse Ly-6C HK1.4 FC
TotalSeq™-C0013 anti-mouse Ly-6C HK1.4 PG
TotalSeq™-B0013 anti-mouse Ly-6C HK1.4 PG
APC/Fire™ 810 anti-mouse Ly-6C Antibody HK1.4 FC
Spark Red™ 718 anti-mouse Ly-6C HK1.4 FC
Spark UV™ 387 anti-mouse Ly-6C HK1.4 FC
PE/Fire™ 810 anti-mouse Ly-6C HK1.4 FC
Spark Blue™ 550 anti-mouse Ly-6C (Flexi-Fluor™) HK1.4 FC
Spark Blue™ 574 anti-mouse Ly-6C (Flexi-Fluor™) HK1.4 FC
PE/Cyanine5 anti-mouse Ly-6C HK1.4 FC
Spark PLUS B550™ anti-mouse Ly-6C HK1.4 FC
PerCP/Fire™ 806 anti-mouse Ly-6c Antibody HK1.4 FC
Go To Top Version: 2    Revision Date: 12/09/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account